KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Asset Writedowns and Impairment (2016 - 2020)

Historic Asset Writedowns and Impairment for Chemed (CHE) over the last 10 years, with Q4 2020 value amounting to -$443000.0.

  • Chemed's Asset Writedowns and Impairment changed N/A to -$443000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $613000.0, marking a year-over-year change of. This contributed to the annual value of $657000.0 for FY2020, which is N/A changed from last year.
  • As of Q4 2020, Chemed's Asset Writedowns and Impairment stood at -$443000.0.
  • In the past 5 years, Chemed's Asset Writedowns and Impairment registered a high of $4.7 million during Q3 2017, and its lowest value of -$443000.0 during Q4 2020.
  • In the last 3 years, Chemed's Asset Writedowns and Impairment had a median value of $4.0 million in 2016 and averaged $2.9 million.
  • Within the past 5 years, the most significant YoY rise in Chemed's Asset Writedowns and Impairment was 3304.73% (2016), while the steepest drop was 122.14% (2016).
  • Chemed's Asset Writedowns and Impairment (Quarter) stood at $4.2 million in 2016, then rose by 3.96% to $4.4 million in 2017, then tumbled by 110.18% to -$443000.0 in 2020.
  • Its last three reported values are -$443000.0 in Q4 2020, $185000.0 for Q3 2020, and $277000.0 during Q2 2020.